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PURPOSE. To assess the reproducibility of the ocular response
analyzer (ORA) in nonoperated eyes and the impact of corneal
biomechanical properties on intraocular pressure (IOP) mea-
surements in normal and glaucomatous eyes.
METHODS. In the reliability study, two independent examiners
obtained repeated ORA measurements in 30 eyes. In the clin-
ical study, the examiners analyzed ORA and IOP-Goldmann
values from 220 normal and 42 glaucomatous eyes. In both
studies, Goldmann-correlated IOP measurement (IOP-ORAg),
corneal-compensated IOP (IOP-ORAc), corneal hysteresis
(CH), and corneal resistance factor (CRF) were evaluated. IOP
differences of 3 mm Hg or greater between the IOP-ORAc and
IOP-ORAg were considered outcome significant.
RESULTS. Intraexaminer intraclass correlation coefficients and
interexaminer concordance correlation coefficients ranged
from 0.78 to 0.93 and from 0.81 to 0.93, respectively, for all
parameters. CH reproducibility was highest, and the IOP-ORAg
readings were lowest. The median IOP was 16 mm Hg with the
Goldmann tonometer, 14.5 mm Hg with IOP-ORAg (P 
0.001), and 15.7 mm Hg with IOP-ORAc (P  0.001). Out-
come-significant results were found in 77 eyes (29.38%). The
IOP-ORAc, CH, and CRF were correlated with age (r  0.22,
P  0.001; r  0.23, P  0.001; r  0.14, P  0.02,
respectively), but not the IOP-ORAg or IOP-Goldmann.
CONCLUSIONS. The ORA provides reproducible corneal biome-
chanical and IOP measurements in nonoperated eyes. Consid-
ering the effect of ORA, corneal biomechanical metrics pro-
duces an outcome-significant IOP adjustment in at least one
quarter of glaucomatous and normal eyes undergoing noncon-
tact tonometry. Corneal viscoelasticity (CH) and resistance
(CRF) appear to decrease minimally with increasing age in
healthy adults. (Invest Ophthalmol Vis Sci. 2008;49:968–974)
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Intraocular pressure (IOP) elevation is most commonly asso-ciated with glaucoma.1 Although analyzing the anatomic
structure and visual function are of pivotal importance,2,3 ac-
curately measuring IOP remains challenging.4,5 The Goldmann
tonometer (GT) is the gold standard. However, some corneal
factors can affect the accuracy of the GT, such as corneal
thickness, corneal curvature, edematous and scarred corneas,
keratoconus, and corneal rigidity.6–10
A new noncontact tonometer (NCT; Ocular Response Ana-
lyzer [ORA]; Reichert, Delpew, NY) uses a rapid air impulse
and an advanced electro-optical system to record two applana-
tion pressures (Fig. 1) during corneal movements in and out.11
However, the cornea resists the dynamic air puff, causing
delays in the inward and outward movement, resulting in two
pressure values, the average of which is the Goldmann-corre-
lated IOP measurement (IOP-ORAg).11 Corneal hysteresis (CH)
is a new measurement of corneal tissue properties reflecting
the tissue capacity to absorb and dissipate energy.11 CH may,
therefore, have a prominent role in obtaining an IOP estimate
of the true IOP with fewer corneal artifacts. Furthermore, CH
may provide new information about biomechanical corneal
properties useful for indicating keratorefractive surgery and
planning retreatment to avoid iatrogenic keratectasia.12–15 CH
also provides a basis for two new parameters, corneal-compen-
sated IOP (IOP-ORAc), which is mathematically derived from
CH and is intended to produce improved IOP estimates—an
assumption that should be confirmed by manometric studies—
and corneal resistance factor (CRF), which appears to indicate
corneal “resistance” (Luce DA, personal communication,
2005). Although CH may reflect mostly corneal viscosity, CRF
(defined as a linear function of the inward and outward appla-
nation pressures) may predominantly relate to the elastic prop-
erties of the cornea.16
CH, which does not vary diurnally,17,18 decreases in glau-
comatous eyes11,19 and may have an implication in glaucoma
damage20 that only longitudinal studies will demonstrate. How-
ever, there are possible systematic and random possible
sources of error with any tonometer.21 Whereas the former are
adjustable,22 the latter are inherent in instrument design and
quality, can only be assessed by repeated measurements on the
same patient, and are not adjustable.21 The ORA has a varying
systematic error compared with the GT, depending on the
ORA prototype22,23 or the production unit tested,16,19 that can
be further calibrated.22 To our knowledge, no study has ana-
lyzed ORA repeatability for IOP estimations and biomechanical
parameters, a need that other authors22 share with us.
The aims of the present study were to evaluate the preci-
sion of the ORA IOP and biomechanical corneal measurements
by assessing intraobserver and interobserver reproducibility,
evaluating the effects of the ORA corneal biomechanical prop-
erties on IOP adjustment by NCT in nonoperated eyes, and
assessing a possible relationship between ORA parameters
(compared with GT reading) and age in a healthy population.
MATERIALS AND METHODS
A prospective, cross-sectional study was performed to evaluate IOP
measurements using the ORA in nonoperated eyes. Informed consent
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was obtained from each patient according to the tenets of the Decla-
ration of Helsinki.
Reproducibility Study
Three repeated measurements (each measurement was the average of
three good-quality readings) by two examiners were obtained to eval-
uate the intraoperator and interoperator reproducibility of the same
instrument. A good-quality reading was defined as one that exhibited
force-in and force-out applanation signal peaks on the ORA wavefront
that were fairly symmetrical in height. Interoperator repeatability was
assessed by comparing the results of one examination by one examiner
with one performed in the same eye in the same session by another
examiner. Each eye was assigned a random order for the operators.24
Between examinations, the device was moved away from the subject,
and the operator left the room and waited 5 minutes so that the
examiner repositioned the patient before performing another exami-
nation. Thirty eyes (30 healthy patients) were included. Exclusion
criteria included corneal astigmatism 3 diopters and any previous
ocular surgery.
Clinical Study
We obtained IOP measurements by ORA and GT in 262 consecutive
eyes (262 patients), of which 42 had a diagnosis of primary open-angle
glaucoma and 220 were normal. The same exclusion criteria as for the
reliability study were used. One eye of each patient was selected
randomly and determined to have a healthy cornea by meticulous
biomicroscopic examination. Of the 42 glaucomatous eyes, 16 (38%)
received a primary diagnosis; the remaining 26 (62%) were already
receiving topical IOP-lowering medications. All ORA measurements
were obtained using the same calibrated instrument by the same
examiner. An independent examiner masked as to the ORA results
obtained the GT values using a calibrated Goldmann handheld tonom-
eter (Perkins; Columbus, OH). We evaluated the IOP-ORAg, IOP-ORAc,
CH, and CRF using the ORA tonometer and the IOP obtained by the
GT. The average of three readings from each tonometer was recorded.
If one measurement was incorrect (not meeting the good-quality re-
quirements in ORA measurements and distortions or excessive narrow-
ing or widening of the normal-appearing fluorescein bands in GT
measurements), the measurement was repeated. The ORA measure-
ment was taken before Goldmann IOP to avoid the effect of topical
anesthesia on NCT measures25–27 and to prevent bias of ORA markers
of corneal biomechanical properties by previous applanation tonome-
tries or by corneal modification from corneal anesthesia.22 Moreover,
we have previously demonstrated that after three repeated air-puffs,
IOP readings do not decrease noticeably.28
To evaluate the effect of the ORA corneal biomechanical metrics
on NCT values (IOP-ORAc), measurement-significant adjustments
(IOP-ORAc minus IOP-ORAg) were defined as IOP corrections of
1.5 mm Hg or greater.29 Similarly, any ORA biomechanically
derived IOP adjustments of3.0 mm Hg were designated as outcomes-
significant.29
All analyses were performed using the SPSS program (version 13.0
for Windows; SPSS Inc., Chicago, IL) and the Stata program (version
9.0 for Windows; Statcorp LP, College Station, TX). Significance was
determined by the Mann-Whitney U nonparametric test, and data were
expressed as medians and 25% and 75% interquartile ranges (IRs)
because the values were found to be nonnormally distributed. The
association between two variables was tested using the Spearman
correlation coefficient given the nonnormal distribution of at least one
variable. The significance level was set at P 0.05, by a two-tailed test.
Agreement between IOP measurements was evaluated as described by
Bland and Altman.21
To assess intraoperator repeatability, we calculated the within-
subject SD (sw) of two consecutive measurements in each eye by one
examiner.30 Precision (repeatability coefficient) was defined as 1.96
sw.
30 The difference between a subject’s measurement and the true
value from a statistical standpoint was expected to be1.96 sw for 95%
of the observations.12 We computed the “repeatability” (2.77. sw),
which is another useful way of presenting measurement error30 and
which represents the value below which we expected 95% of the
absolute differences between two measurements to lie.30,31 We also
calculated the intrasession reliability of the measurement method with
the intraclass correlation coefficient (ICC).21
To assess interoperator reproducibility, a Bland-Altman plot
showed the difference between both examiners’ readings against
the average of the two.21 Provided that the differences were nor-
mally distributed and no association between the measurement and
the difference was shown, each 95% limit of agreement (LoA) was
calculated as the average difference in measurements from the two
examiners 1.96 SD (SD); lower values indicated higher interop-
erator repeatability.31 The paired t-test also established whether
there was a significant systematic bias between measurements from
different examiners. The interoperator reliability of the measure-
ment method was calculated with the concordance correlation
coefficient (CCC).32
FIGURE 1. Profiles corresponding to
an ORA measurement of IOP and cor-
neal biomechanical properties.
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RESULTS
Reproducibility Study
The intraexaminer within-subject SDs ranged from 1.45 mm Hg
for CH to 3.33 mm Hg for IOP-ORAg (Table 1). Precision
ranged from 2.85 mm Hg for CH to 6.53 mm Hg for IOP-ORAg.
Repeatability, which ranged from 4.03 to 9.23 mm Hg, was
better for CH than for CRF and for IOP-ORAc than for IOP-
ORAg. Intraexaminer reliability (ICC) ranged from 0.78 to 0.93
(good to excellent) for the ORA parameters and tended to be
slightly better for ORA biomechanical metrics than for ORA
IOP readings, though the difference was not significant be-
cause all 95% confidence intervals (CIs) overlapped.
Interexaminer reproducibility average differences and their
corresponding 95% LoA illustrated the closeness between ex-
aminers (Table 2, Figs. 2, 3). No significant difference in the
mean value of each parameter was found between examiners;
the narrow 95% LoA indicated that measurements obtained by
both examiners were interchangeable. CCC values and 95% CIs
confirmed this. For all ORA parameters, the CCCs were very
high, ranging from 0.81 to 0.93. All CIs excluded the null value
of 0, indicating their significance. The markers of corneal
biomechanical properties showed a trend toward better CCC
values than the ORA IOP measurements, but the difference did
not reach statistical significance.
Clinical Study
Of the 262 eyes (median age, 69 years; IR, 55–75 years; range,
19–88 years) included in this segment, 42 had a diagnosis of
primary open-angle glaucoma (median age, 63 years; IR, 50–72
years); 220 were normal (median age, 69 years; IR, 55–76 years).
The median IOP in all eyes was 16 mm Hg (IR, 14–18) using
GT, 14.5 mm Hg (IR, 12.7–17.3) with IOP-ORAg, and 15.7 mm
Hg (IR, 13.22–18.7) with IOP-ORAc. The differences were
significant between GT and IOP-ORAg (P  0.001) and be-
tween GT and IOP-ORAc (P  0.001).
The median difference in all eyes between IOP-ORAc and
IOP-ORAg was 1.5 mm Hg (IR, 0.7–3.0; P  0.001). This
median difference did not differ significantly between normal
and glaucomatous eyes (1.5 mm Hg [IR, 0.7–3.0] and 1.7 mm
Hg [IR, 0.92–3.7], respectively; P  0.34). Figure 4 shows the
corresponding scatter and Bland-Altman plots between IOP-
ORAc and IOP-ORAg; each 95% LoA was wide (3.32–5.57
mm Hg), indicating these ORA parameters are not interchange-
able.
In this series, 135 eyes (51.5%) had at least a measurement-
significant adjustment in the NCT examination after the ORA
markers of corneal biomechanical properties were considered.
IOP-ORAg was lower than IOP-ORAc by 1.5 mm Hg in 26
eyes (9.9%) and higher than IOP-ORAc by 1.5 mm Hg in 109
eyes (41.6%). IOP-ORAg was lower than IOP-ORAc by 3 mm
Hg in 9 eyes (3.4%) and higher than IOP-ORAc by 3 mm Hg
in 68 eyes (25.9%).
Twenty-two glaucomatous eyes (52.3%) had at least a mea-
surement-significant adjustment in their NCT examination after
ORA corneal biomechanical metrics were considered. IOP-
ORAg was lower than IOP-ORAc by 1.5 mm Hg in 5 eyes
(11.9%) and higher than IOP-ORAc by 1.5 mm Hg in 17 eyes
(40.4%). Outcomes-significant IOP changes were detected in
13 eyes (30.9%). IOP-ORAg was lower than IOP-ORAc by 3
mm Hg in 2 eyes (4.76%) and higher than IOP-ORAc by3 mm
Hg in 11 eyes (26.2%).
One hundred thirteen normal eyes (51.3%) had at least a
measurement-significant adjustment in their NCT examination
after ORA markers of corneal biomechanical properties were
considered. IOP-ORAg was lower than IOP-ORAc by 1.5 mm
Hg in 21 eyes (9.5%) and higher than IOP-ORAc by 1.5 mm
Hg in 92 eyes (41.8%). Outcomes-significant IOP changes were
detected in 64 eyes (29.1%). IOP-ORAg was lower than IOP-
ORAc by 3 mm Hg in 7 eyes (3.2%) and higher than IOP-
ORAc by 3 mm Hg in 57 eyes (25.9%).
Table 3 shows a comparison of the IOP values, CRF, and CH
in normal and glaucomatous eyes. Only CH was not signifi-
cantly different between the groups.
In the entire series, IOP-ORAc was weakly positively corre-
lated with age (rs  0.18, P  0.005), whereas IOP-ORAg and
GT were not (rs  0.03, P  0.59; rs  0.03, P  0.67,
respectively). CH and CRF were inversely correlated with age
(rs  0.26, P  0.001; rs  0.19, P  0.002, respectively).
In glaucomatous eyes, IOP-ORAc was positively correlated
with age (rs  0.34, P  0.02), whereas IOP-ORAg and GT
were not (rs  0.22, P  0.16; rs  0.13, P  0.42, respec-
tively). CH but not CRF was inversely correlated with age (rs
0.33, P  0.03; rs  0.12, P  0.44, respectively).
In normal eyes, IOP-ORAc was weakly positively correlated
with age (rs  0.22, P  0.001), whereas IOP-ORAg and GT
were not (rs  0.07, P  0.29; rs  0.07, P  0.92, respec-
tively). CH and CRF were inversely correlated with age (rs 
0.26, P  0.001; rs  0.18, P  0.006, respectively).
TABLE 1. ORA Intraexaminer Repeatability: Within-Subject Standard Deviation (sw), Precision (1.96 sw), Repeatability (2.77 sw) Scores, and
Reliability (ICC)
ORA Parameter sw (mm Hg) Precision (mm Hg) Repeatability (mm Hg) Reliability (95% CI)
Goldmann-correlated IOP 3.333 6.53 9.23 0.93 (0.87–0.95)
Corneal-compensated IOP 2.384 4.67 6.60 0.78 (0.48–0.89)
Corneal resistance factor 1.946 3.81 5.39 0.93 (0.84–0.96)
Corneal hysteresis 1.454 2.85 4.03 0.84 (0.67–0.92)
TABLE 2. ORA Interexaminer Reproducibility: Mean Difference between Examiners, 95% LoA, and CCC
ORA Parameter Average Difference (mm Hg) 95% LoA (mm Hg) CCC (95% CI)
Goldmann-correlated IOP 0.05 2.87, 2.97 0.89 (0.82–0.97)
Corneal-compensated IOP 0.05 2.68, 2.79 0.81 (0.68–0.94)
Corneal resistance factor 0.023 1.38, 1.34 0.93 (0.89–0.98)
Corneal hysteresis 0.06 1.07, 1.19 0.92 (0.87–0.98)
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DISCUSSION
We obtained excellent intraexaminer reliability scores (0.9)
for Goldmann-correlated IOP and CRF (Table 1) and found
clinically useful reliability estimates (0.7)33 in the IOP-ORAc
and CH. These values are similar to those for other tonometers
and are considered by previous authors as clinically ade-
quate.33 The ICCs for rebound tonometry34 were 0.82, 0.73,
and 0.87, respectively, for the first, second, and third examin-
ers, and the ICCs for the GT and tonometer (Tono-Pen;
Reichert) were 0.97 and 0.95, respectively.35 Although no
significant difference was found, ORA corneal biomechanical
metrics showed a trend toward slightly better than ORA IOP
readings, perhaps because corneal tissue biomechanical prop-
erties are fairly constant, whereas the IOP changes with the
cardiac cycle, and NCT measures the IOP within 1 to 3 ms,
making the ocular pulse a crucial source of variability.36 Ko-
techa et al.22 found that the coefficient of variation of ORA IOP
measurements was four to five times greater than that of GT
IOP measurements. However, they calculated coefficients of
variation for CH and CRF nearly twice as high as those for
IOP-ORAc. Differences between the studies might have oc-
curred because our ORA was a commercially available unit,
whereas theirs was a prototype,22 and because we averaged
three repeated ORA readings and they did not, with averaging
favoring more corneal biomechanical metrics than ORA IOP
readings. The ability to yield reliable corneal biomechanical
metrics is an outstanding feature of the ORA when determining
candidates for keratorefractive surgery or for retreat-
ments.13–16 Given the growing concern about iatrogenic ker-
atectasia,12–15 ORA biomechanical parameters may contribute
significantly to preoperative screening of patients who are not
candidates for keratorefractive surgery or who seek surgical
alternatives because of a biomechanically compromised cor-
nea.12,16
Table 1 also shows the sw for each ORA parameter. The
precision results corroborated our ICC findings. These three
estimates differentiate between statistically and clinically sig-
nificant changes when different datasets obtained with the
same ORA unit are compared.
When the ORA measurements recorded by two examiners
were compared, the mean differences were not significantly
FIGURE 2. Bland-Altman plot showing the agreement between exam-
iners 1 and 2 in measuring (A) IOP-ORAc in mm Hg and (B) IOP-ORAg
in mm Hg (30 healthy eyes; median age, 29 years; 25% and 75%
interquartile ranges, 23.75–33 years).
FIGURE 3. Bland-Altman plot showing agreement between examiners
1 and 2 in measuring (A) ORA CH (mm Hg) and (B) ORA CRF in mm
Hg (30 normal eyes; median age, 29 years; 25% and 75% interquartile
ranges, 23.75–33 years).
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different from 0 (Table 2). Not surprisingly, no difference in
ORA measures was found, indicating that whatever the source
of the variability, the interobserver variability was random. The
95% LoA (Table 2) provided useful guidelines for the variability
expected using the ORA by two examiners. In fact, the ampli-
tude of the 95% LoA was narrow, indicating that ORA readings
obtained by both examiners were interchangeable. These data
and the CCCs indicated that the reliability of ORA IOP and
corneal biomechanical parameters obtained by different exam-
iners were good to excellent: CCCs 0.81 indicated almost
perfect agreement,32,37 as with the four ORA parameters.
These findings also indicated that no examiner bias affected the
results. These reproducibility data were similar to those of
other tonometers: the ICC of the rebound tonometer was
0.82,34 with similar figures reported for other tonom-
eters.38–40 Overall, our results suggested that ORA reproduc-
ibility was similar to or better than that of other tonom-
eters.34,35,38–41
Although it was not a primary aim of the present study to
establish a correlation between GT to IOP-ORA measurements,
we also studied the GT to determine whether IOP-ORAg was
similar to GT and whether ORA parameters and GT are influ-
enced by age to the same extent in the same group of patients.
We found significant systematic differences between the IOP-
ORAc and IOP-ORAg provided by the ORA and the IOP-GT
readings; the latter provided higher readings. Such differences
cannot be attributed to bias related to the order of IOP mea-
surements because repeated measures lead to a tonometric
effect that reduces24,42 the IOP and because topical anesthetics
may cause corneal drying and an associated drop in IOP,26,27 in
contrast to the current results. The systematic difference be-
tween our IOP-ORAg and GT, which was not as large as
reported after an ORA prototype was analyzed,23 agrees with
the findings of others16,19 and probably represents a modest
calibration error that can be further adjusted.22 Nevertheless,
NCTs are useful for population surveys; no corneal contact or
topical anesthesia are needed, which eliminates corneal distur-
bance,43 and the instruments lower the risk for transmitting
communicable diseases.44 However, great variations occur
with NCTs,45 partially because of the cardiac pulse.25,36,46–49
When comparing three NCTs with the GT, we found better
sensitivity and positive predictive values for detecting IOP20
mm Hg than in the present study using IOP-ORAc and IOP-
ORAg.50
The median IOP difference between IOP-ORAc and IOP-
ORAg was 1.5 mm Hg, which was not significantly different
from that comparing normal with glaucomatous eyes and was
similar to that of other studies.23 Bland-Altman analysis con-
firmed that the parameters are not interchangeable and that
they represent two different estimations. We found that con-
sidering the biomechanical properties measured by the ORA
resulted in a considerable modification (3 mm Hg) in 29% of
the IOP measurements, a higher percentage than the 20% of
the IOP measurements Shih et al. found considering the effect
of central corneal thickness (CCT),29 which suggests that the
ORA integrates more complex and complete biomechanical
properties than CCT does on its own. This 29% was essentially
uniform across normal and glaucomatous eyes, and 25% to 26%
corresponded to higher IOP-ORAg readings than IOP-ORAc
readings. Thus, in nonoperated eyes, IOP-ORAc measurements
showed that nearly 25% of persons had a notably lower reading
than that obtained with a conventional NCT and that another
3% to 4% had markedly higher IOP measurements than those
obtained with a conventional NCT. These adjustments may
lead to, respectively, elimination of unneeded diagnostic and
therapeutic actions and early diagnosis and timely treatment of
truly glaucomatous eyes.29,51–53
In our study, ORA corneal biomechanical parameters
showed that the median CH was 9.3 mm Hg in glaucomatous
and normal eyes compared with 9.6 mm Hg reported previ-
ously in normal eyes.11 Herndon4 and Luce11 reported that CH
is independent of IOP. Laiquzzaman et al.17 found no signifi-
cant relationship between CH and IOP. Interestingly, Congdon
et al.20 found that lower CH is associated with visual field
damage in glaucomatous eyes. CCT and CH may constitute
pressure-independent risk factors for glaucoma, perhaps re-
lated to eye wall composition.20 Furthermore, CH does not
vary diurnally,17,18 in contrast to IOP17,18 and corneal thick-
ness.18
There is a likely effect of age on physical corneal proper-
ties.22,54,55 We analyzed 220 healthy adults at an interquartile
age range of 55 to 76 years, when most glaucoma diagnoses are
made.56,57 In contrast to that observed for a comparably nar-
rower age range in a pediatric population,19 CH and CRF
decreased in normal eyes with increasing age, which corrob-
orates analyses from a mixed population of normal and glau-
comatous eyes.22 Such results can be explained because the
FIGURE 4. Corresponding scatter and Bland-Altman plots between
IOP-ORAc (mm Hg) and IOP-ORAg in mm Hg (220 normal and 42
glaucomatous eyes; median age, 69 years; 25% and 75% interquartile
ranges, 55–75 years).
TABLE 3. Comparison of Evaluated Data between Normal and Glaucomatous Eyes
Values Number
IOP
Goldmann
Goldmann-Correlated
IOP in ORA
Corneal-Compensated
IOP in ORA
Corneal
Resistance
Corneal
Hysteresis
Normal 220 15 (13–17) 14 (12.3–16.7) 15 (13–18) 9.3 (8–10.5) 9.3 (8–10.65)
Glaucoma 42 18 (14.25–20) 17.3 (14.45–22.07) 18.3 (15.45–21.4) 10.3 (8.9–12) 9.3 (7.22–10.77)
P * 0.001 0.001 0.001 0.006 0.83
Data are expressed as median values in mm Hg (75% interquartile range).
* Mann-Whitney nonparametric test.
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aging cornea increases in rigidity and decreases in viscoelastic-
ity with time,22,54,55 which is consistent with the inverse cor-
relation we found between CH and age but not with the weak
negative correlation between CRF and age. However, in glau-
comatous eyes, the CRF did not correlate with age compared
with CH, possibly because although corneal rigidity should be
expected to increase with age, likely because of additional
cross-linking, the impact of increasing IOP on CRF is unknown.
Interestingly, in normal and glaucomatous eyes, IOP-ORAc
but not IOP-ORAg or GT, readings correlated significantly with
increasing age. Further longitudinal studies may confirm this
preliminary association.
This study had limitations. The number of patients with
glaucoma was relatively small, but statistical differences in GT,
IOP-ORAc, and IOP-ORAg were found between eyes with
and without glaucoma. Nevertheless, the present study was
the largest independent clinical study evaluating ORA to date.
In addition, no measurements of corneal thickness were con-
sidered; however, the effect of corneal thickness was in-
cluded in other corneal parameters, such as CRF, and the
relationship between CCT and ORA parameters has been stud-
ied extensively.22,23,58,59 Finally, it is difficult to know whether
the definition of measurement-significant (1.5 mm Hg) and
outcomes-significant (3.0 mm Hg) are useful in IOP adjust-
ments, but these cutoff values were defined previously.29 De-
spite limitations, this study was the first to evaluate the repro-
ducibility of a production ORA unit and the practical effect of
corneal biomechanical parameters on IOP measurements in
nonoperated eyes. We believe the current report is a valuable
contribution to the assessment of IOP measurements with a
new NCT and noninvasive markers of corneal biomechanical
properties.
Our results showed overall good intraexaminer and inter-
examiner reproducibility for ORA measurements in non-
operated eyes, with the corneal biomechanical metrics show-
ing a trend toward the performance of slightly better than the
IOP estimates. Consequently, the ability to provide reliable
readings heralds a relevant role for the ORA in diagnosing
glaucoma4,22 and in assessing cornea patients or candidates for
corneal-weakening surgeries.12–16 This study also showed that
accounting for the ORA corneal biomechanical metrics in the
IOP measurement would associate an outcomes-significant ad-
justment of the NCT reading in 29% of the tested eyes, which
has overt screening and cost-related implications.52,60 Finally,
patients with both normal and glaucomatous eyes have signif-
icant associations between increasing age and decreasing CH
and CRF and increasing IOP-ORAc but no association with
other IOP estimates. Future studies should address whether
IOP-ORAc is a better estimate of the true IOP than other
existing tonometry alternatives in nonoperated eyes. The risk
for glaucoma increases with age,56,57 and elevated IOP is a risk
factor for glaucoma56,57 and the one that constitutes the main
therapeutic target in this prevalent eye disease.4,56,57
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